1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Tenapanor
Trade Name:
Ibsrela
Manufacturer/Distributor:
Knight Therapeutics Inc.
Classification:
Sodium/hydrogen exchanger inhibitor
ATC Class:
A03AX - other drugs for functional bowel disorder
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/04/15
Date Marketed in Canada (yyyy/mm/dd):
2020/11/23
Presentation:
Tablet: 50 mg. DIN: 02498049
Comments:
For treatment of irritable bowel syndrome with constipation in adults.
Source:
Product monograph
Back to:
Drug Product Listings 
